STAT

Opinion: ‘Benign sexism’ intrudes at a meeting of the world’s brightest minds

Even in the wake of the #MeToo moment, we still find ourselves confronting sexism in what we perceive to be the most progressive, sophisticated spaces.

It’s 2018. We’re in the wake of the #MeToo moment. Increased reporting is exposing rampant sexism in medicine, media, and beyond. Women are now more empowered than ever to speak up in response to bias and harassment. One could think we’ve come a long way.

And yet, for all our expressed outrage at widespread sexual harassment and our newfound “wokeness” about gender equity, we still find ourselves confronting sexism in what we perceive to be the most progressive, sophisticated spaces.

That was driven home where two of us (E.M. and N.N.) were honored to be part of a panel discussing the growing epidemic of clinician burnout in the United

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.

Related Books & Audiobooks